Can a high dose vitamin E supplementation delay the onset of Alzheimer’s disease?
A recent study by Professor Maurice Dysken of the University of Minnesota Medical School provides data that indicates that high dose vitamin E supplementation could be useful as a therapeutic treatment to delay the onset of Alzheimer’s disease.
Simple flour fortification is an effective means of reducing the incidence of anemia on a national scale
A systematic assessment has found that each year of flour fortification was associated with a 2.4% reduction in the prevalence of anemia. There was no reduction in those countries that did not fortify.
Mild Cognitive Impairment (MCI) is a condition in elderly people associated with a higher risk of developing dementia. At present, there are no effective pharmacological treatments for Alzheimer’s Disease (AD), so scientists are now concentrating their efforts on finding effective interventions in the pre-clinical stages of dementia, such as MCI.
A new paper from Jerneren et al. reworks data from a human double-blinded, randomized controlled trial that had shown that homocysteine-lowering B vitamins were able to reduce brain shrinkage in people with MCI. They found the beneficial effect was highly dependent on the patients’ plasma docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) status. In the highest DHA/EPA tertile, brain atrophy rates were reduced by an average of 40%, whereas there was no reduction at all in the lowest tertile.
Crohn’s disease is a lifelong inflammatory bowel disease which affects the gastrointestinal tract. The underlying causes are unknown. Low vitamin D levels have previously been implicated in severe attacks. A new randomized, double-blind, placebo-controlled study conducted by Raftery et al. at St James’s Hospital in Dublin, Ireland, indicates that vitamin D supplementation may prolong remission in Crohn’s disease patients.